Stay updated on Pembrolizumab and Chemotherapy in Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Chemotherapy in Breast Cancer Clinical Trial page.

Latest updates to the Pembrolizumab and Chemotherapy in Breast Cancer Clinical Trial page
- Check7 days agoChange DetectedRevision: v3.5.2 added and v3.5.0 removed.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check36 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check43 days agoChange DetectedRevision: v3.4.3 added and Revision: v3.4.2 removed to reflect the latest site version.SummaryDifference0.0%

- Check71 days agoChange DetectedThe site shows a minor update: a new Revision: v3.4.2 label was added and older Revision: v3.4.1 and a government funding-status notice were removed. These changes do not affect the study content, eligibility criteria, or results, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check78 days agoChange DetectedAdds a government funding notice about the NIH Clinical Center’s status and updates the page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check85 days agoChange DetectedShow glossary option is now displayed on the page, and new metadata items were added: Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0. The items Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4 were removed.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab and Chemotherapy in Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Chemotherapy in Breast Cancer Clinical Trial page.